Packaging and labeling of cannabis-infused edibles are unregulated at the federal level due to Cannabis remaining a Schedule I drug, therefore industry must comply with individual state codes and use international standards for guidance. Cannabis-infused edibles are packaged and labeled with all the familiar requirements for a food and dietary supplement, and further requirements must be met.
A recent study has found pervasive, low levels of lead, cadmium, arsenic, mercury, and phthalates in U.S. cannabidiol products. The study also demonstrated substantial inaccuracies of product label claims for CBD potency.
The U.S. Food and Drug Administration (FDA) recently announced that consumers should not ingest any marijuana-infused products that contain delta-8 THC, aka delta-8 tetrahydrocannabinol.
